[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100055274":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":7,"locations":16,"responsibleParty":7,"collaborators":7,"id":40,"slug":41,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":7,"eligibilityCriteria":46,"healthyVolunteers":42,"sex":47,"minAge":48,"maxAge":7,"enrollmentInfo":49,"targetDuration":7,"studyType":51,"phases":52,"briefSummary":54,"conditions":55,"keywords":57,"overallStatus":63,"whyStopped":7,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":7,"completionDateStruct":7,"leadSponsor":68,"locationsCount":70},{"fullName":5,"class":6},"NIH AIDS Clinical Trials Information Service","INDUSTRY",null,[9,12,14],{"type":10,"name":11,"description":7,"armGroupLabels":7,"otherNames":7},"DRUG","Saquinavir",{"type":10,"name":13,"description":7,"armGroupLabels":7,"otherNames":7},"Lamivudine",{"type":10,"name":15,"description":7,"armGroupLabels":7,"otherNames":7},"Zidovudine",[17,30],{"facility":18,"status":7,"city":19,"state":20,"zip":21,"country":22,"countryCode":23,"cosmosGeoPoint":24,"geoPoint":29,"contacts":7},"AIDS Healthcare Foundation Labs","Los Angeles","California","90048","United States","US",{"type":25,"coordinates":26},"Point",[27,28],-118.24368,34.05223,{"lat":28,"lon":27},{"facility":31,"status":7,"city":32,"state":33,"zip":34,"country":22,"countryCode":23,"cosmosGeoPoint":35,"geoPoint":39,"contacts":7},"Urgent Care Ctr \u002F North Broward Hosp District","Fort Lauderdale","Florida","33316",{"type":25,"coordinates":36},[37,38],-80.14338,26.12231,{"lat":38,"lon":37},"100055274","phase-3-a-study-of-saquinavir-soft-gelatin-capsules-plus-zidovudine-plus-lamivudine-in-the-treatment-of-hiv-1-infected-patients-who-have-never-taken-anti-hiv-drugs-100055274",false,"NCT00002367","A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs","An Open-Label, Non-Comparative Study of Saquinavir-SGC in Combination With Zidovudine (AZT) and Lamivudine (3TC) in the Treatment of HIV-1 Infected Patients With No Previous Anti-Retroviral Drug Therapy","Inclusion Criteria\n\nPatients must have:\n\n* Plasma HIV-1 RNA titers \\> 10,000 copies\u002Fml.\n* CD4 cell count \\> 100 cells\u002Fmm3.\n\nExclusion Criteria\n\nCo-existing Condition:\n\nPatients with any of the following conditions will be excluded:\n\n* Any prior anti-retroviral drug therapy.\n\nPrior Medication:\n\nExcluded:\n\nPrevious anti-retroviral drug therapy.","ALL","16 Years",{"count":50,"type":7},40,"INTERVENTIONAL",[53],"PHASE3","To evaluate the efficacy of Saquinavir-SGC combination with Zidovudine and Lamivudine in the treatment of HIV-1 infected patients with no previous anti-retroviral drug therapy.",[56],"HIV Infections",[58,59,15,60,13,11,61,62],"Drug Therapy, Combination","Acquired Immunodeficiency Syndrome","HIV Protease Inhibitors","Reverse Transcriptase Inhibitors","Anti-HIV Agents","COMPLETED","2005-06-23",{"date":66,"type":67},"2005-06-24","ESTIMATED",{"name":69,"class":6},"Hoffmann-La Roche",2]